Application 040745

Type: ANDA
Sponsor: BAXTER HLTHCARE

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	CYCLOPHOSPHAMIDE	CYCLOPHOSPHAMIDE	INJECTABLE;INJECTION	500MG/VIAL	No	Yes
002	CYCLOPHOSPHAMIDE	CYCLOPHOSPHAMIDE	INJECTABLE;INJECTION	1GM/VIAL	No	Yes
003	CYCLOPHOSPHAMIDE	CYCLOPHOSPHAMIDE	INJECTABLE;INJECTION	2GM/VIAL	No	Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A040745-001	CYCLOPHOSPHAMIDE	CYCLOPHOSPHAMIDE	500MG/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21
A040745-002	CYCLOPHOSPHAMIDE	CYCLOPHOSPHAMIDE	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21
A040745-003	CYCLOPHOSPHAMIDE	CYCLOPHOSPHAMIDE	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A040745-001	AP
A040745-002	AP
A040745-003	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A040745-001	CYCLOPHOSPHAMIDE	500MG/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A040745-002	CYCLOPHOSPHAMIDE	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A040745-003	CYCLOPHOSPHAMIDE	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A040745-001	CYCLOPHOSPHAMIDE	500MG/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A040745-002	CYCLOPHOSPHAMIDE	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A040745-003	CYCLOPHOSPHAMIDE	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040745-001	CYCLOPHOSPHAMIDE	500MG/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040745-002	CYCLOPHOSPHAMIDE	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040745-003	CYCLOPHOSPHAMIDE	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A040745-001	CYCLOPHOSPHAMIDE	500MG/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A040745-002	CYCLOPHOSPHAMIDE	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A040745-003	CYCLOPHOSPHAMIDE	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040745-001	CYCLOPHOSPHAMIDE	500MG/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040745-002	CYCLOPHOSPHAMIDE	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040745-003	CYCLOPHOSPHAMIDE	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040745-001	CYCLOPHOSPHAMIDE	500MG/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040745-002	CYCLOPHOSPHAMIDE	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040745-003	CYCLOPHOSPHAMIDE	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040745-001	CYCLOPHOSPHAMIDE	500MG/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040745-002	CYCLOPHOSPHAMIDE	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040745-003	CYCLOPHOSPHAMIDE	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040745-001	CYCLOPHOSPHAMIDE	500MG/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040745-002	CYCLOPHOSPHAMIDE	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040745-003	CYCLOPHOSPHAMIDE	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040745-001	CYCLOPHOSPHAMIDE	500MG/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040745-002	CYCLOPHOSPHAMIDE	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040745-003	CYCLOPHOSPHAMIDE	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040745-001	CYCLOPHOSPHAMIDE	500MG/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040745-002	CYCLOPHOSPHAMIDE	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040745-003	CYCLOPHOSPHAMIDE	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A040745-001	CYCLOPHOSPHAMIDE	500MG/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A040745-002	CYCLOPHOSPHAMIDE	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A040745-003	CYCLOPHOSPHAMIDE	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040745-001	CYCLOPHOSPHAMIDE	500MG/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040745-002	CYCLOPHOSPHAMIDE	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040745-003	CYCLOPHOSPHAMIDE	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040745-001	CYCLOPHOSPHAMIDE	500MG/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040745-002	CYCLOPHOSPHAMIDE	1GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040745-003	CYCLOPHOSPHAMIDE	2GM/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040745-001	CYCLOPHOSPHAMIDE	500MG/VIAL	INJECTABLE / INJECTION	AP	RS	2008-05-21	`1e350fbaab3a…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A040745-001	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A040745-002	AP	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A040745-003	AP	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A040745-001	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A040745-002	AP	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A040745-003	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040745-001	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040745-002	AP	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040745-003	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A040745-001	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A040745-002	AP	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A040745-003	AP	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040745-001	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040745-002	AP	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040745-003	AP	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040745-001	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040745-002	AP	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040745-003	AP	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040745-001	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040745-002	AP	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040745-003	AP	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040745-001	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040745-002	AP	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040745-003	AP	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040745-001	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040745-002	AP	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040745-003	AP	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040745-001	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040745-002	AP	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040745-003	AP	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A040745-001	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A040745-002	AP	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A040745-003	AP	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040745-001	AP	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040745-002	AP	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040745-003	AP	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040745-001	AP	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040745-002	AP	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040745-003	AP	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040745-001	AP	1	`1e350fbaab3a…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 7 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cyclophosphamide	CYCLOPHOSPHAMIDE	BluePoint Laboratories	d7e97b99-83db-42d0-8521-b87fe6467a67	2026-02-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040745 application number: ANDA040745 ndc (product): 68001-442 ndc (product): 68001-444 ndc (product): 68001-443
CYCLOPHOSPHAMIDE	CYCLOPHOSPHAMIDE	Bamboo US Bidco LCC	2873b99a-830d-0a7b-e063-6394a90a4de7	2025-12-03	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040745 application number: ANDA040745
Cyclophosphamide	CYCLOPHOSPHAMIDE	Civica, Inc.	8627c83f-c057-495d-9f78-8b67bda97b3e	2025-10-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040745 application number: ANDA040745 ndc (product): 72572-085 ndc (product): 72572-087 ndc (product): 72572-083
Cyclophosphamide	CYCLOPHOSPHAMIDE	Baxter Healthcare Company	591d9955-3d9c-4cdc-a308-2f1288376b9f	2025-06-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040745 application number: ANDA040745 ndc (product): 10019-955 ndc (product): 10019-957 ndc (product): 10019-956
CYCLOPHOSPHAMIDE	CYCLOPHOSPHAMIDE	Baxter Healthcare Company	97ab446f-5017-4180-ae65-0a355289b0ed	2025-06-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040745 application number: ANDA040745 ndc (product): 10019-938 ndc (product): 10019-939 ndc (product): 10019-942
CYCLOPHOSPHAMIDE	CYCLOPHOSPHAMIDE	Baxter Healthcare Company	cef038cc-efab-46d9-99c2-95bb11d6c9bc	2017-03-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040745 application number: ANDA040745 ndc (product): 10019-944 ndc (product): 10019-945 ndc (product): 10019-943
CYCLOPHOSPHAMIDE	CYCLOPHOSPHAMIDE	Baxter Healthcare Company	6bae5c14-9e87-4fb6-ae9c-4d875c1ecffe	2017-03-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040745 application number: ANDA040745 ndc (product): 10019-937 ndc (product): 10019-936 ndc (product): 10019-935

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 54 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
10019-935	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-935	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-935	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-935	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-936	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-936	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-936	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-936	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-937	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-937	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-937	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-937	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-938	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-938	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-938	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-938	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-939	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-939	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-939	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-939	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-942	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-942	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-942	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-942	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-943	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-943	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-943	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-943	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-944	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-944	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-944	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-944	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-945	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-945	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-945	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-945	CYCLOPHOSPHAMIDE	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-955	Cyclophosphamide	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-955	Cyclophosphamide	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-955	Cyclophosphamide	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-955	Cyclophosphamide	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-956	Cyclophosphamide	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-956	Cyclophosphamide	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-956	Cyclophosphamide	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-956	Cyclophosphamide	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-957	Cyclophosphamide	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-957	Cyclophosphamide	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-957	Cyclophosphamide	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
10019-957	Cyclophosphamide	cyclophosphamide	Baxter Healthcare Corporation	ANDA	Current
68001-442	Cyclophosphamide	cyclophosphamide	BluePoint Laboratories	ANDA	Current
68001-443	Cyclophosphamide	cyclophosphamide	BluePoint Laboratories	ANDA	Current
68001-444	Cyclophosphamide	cyclophosphamide	BluePoint Laboratories	ANDA	Current
72572-083	Cyclophosphamide	cyclophosphamide	Civica, Inc.	ANDA	Current
72572-085	Cyclophosphamide	cyclophosphamide	Civica, Inc.	ANDA	Current
72572-087	Cyclophosphamide	cyclophosphamide	Civica, Inc.	ANDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
17786	SUPPL	2014-10-27
42636	ORIG	2012-03-27